These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7738180)

  • 21. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.
    Day JS; Ding M; Bednarz P; van der Linden JC; Mashiba T; Hirano T; Johnston CC; Burr DB; Hvid I; Sumner DR; Weinans H
    J Orthop Res; 2004 May; 22(3):465-71. PubMed ID: 15099622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs.
    Akahoshi S; Sakai A; Arita S; Ikeda S; Morishita Y; Tsutsumi H; Ito M; Shiraishi A; Nakamura T
    J Bone Miner Metab; 2005; 23(5):341-50. PubMed ID: 16133683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anabolic effects of bisphosphonates on peri-implant bone stock.
    von Knoch F; Eckhardt C; Alabre CI; Schneider E; Rubash HE; Shanbhag AS
    Biomaterials; 2007 Aug; 28(24):3549-59. PubMed ID: 17498799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The microscopic morphology of fluoride-induced bone.
    Vigorita VJ; Suda MK
    Clin Orthop Relat Res; 1983; (177):274-82. PubMed ID: 6407795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of controlled local release of sodium fluoride on trabecular bone.
    Guise JM; McCormack A; Anderson PA; Tencer AF
    J Orthop Res; 1992 Jul; 10(4):588-95. PubMed ID: 1613633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of bisphosphonate for quality and strength of bone].
    Murakami H; Kawahara N; Sakamoto J; Tawara D; Tomita K
    Nihon Rinsho; 2006 Sep; 64(9):1651-6. PubMed ID: 16972674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of sodium fluoride administration to rats on bone phosphorous content and phosphatemia.
    Di Loreto V; Rigalli A; Puche R
    Arzneimittelforschung; 2006; 56(11):760-6. PubMed ID: 17220054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone morphometry and differences in bone fluorine containing compounds in rats treated with NaF and MFP.
    Brun LR; Pera LI; Rigalli A
    Biomed Pharmacother; 2010 Jan; 64(1):1-6. PubMed ID: 19800195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.
    Mashiba T; Turner CH; Hirano T; Forwood MR; Johnston CC; Burr DB
    Bone; 2001 May; 28(5):524-31. PubMed ID: 11344052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Histological effects of the treatment of osteoporosis with the combination of sodium fluoride, vitamin D and calcium].
    Briançon D; Charhon S; Edouard C; Meunier PJ
    Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):693-8. PubMed ID: 7006045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties.
    Guy JA; Shea M; Peter CP; Morrissey R; Hayes WC
    Calcif Tissue Int; 1993 Oct; 53(4):283-8. PubMed ID: 8275358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of fluoride on molecular weight, charge density and age related changes in the sulphated isomers of glycosaminoglycans of the rabbit cancellous bone.
    Sharma K; Susheela AK
    Int J Tissue React; 1988; 10(5):327-34. PubMed ID: 3150760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of local controlled release of sodium fluoride on the stimulation of bone growth.
    Tencer AF; Allen BL; Woodard PL; Self J; L'Heureux A; Calhoun JH; Brown KL
    J Biomed Mater Res; 1989 Jun; 23(6):571-89. PubMed ID: 2738076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The aminobisphosphonate alendronate inhibits bone loss induced by thyroid hormone in the rat. Comparison between effects on tibiae and vertebrae.
    Balena R; Markatos A; Gentile M; Masarachia P; Seedor JG; Rodan GA; Yamamoto M
    Bone; 1993; 14(3):499-504. PubMed ID: 8363899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Sodium Fluoride on Bone Biomechanical and Histomorphometric Parameters and on Insulin Signaling and Insulin Sensitivity in Ovariectomized Rats.
    de Cássia Alves Nunes R; Chiba FY; Pereira AG; Pereira RF; de Lima Coutinho Mattera MS; Ervolino E; Louzada MJ; Buzalaf MA; Silva CA; Sumida DH
    Biol Trace Elem Res; 2016 Sep; 173(1):144-53. PubMed ID: 26876375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effect of sodium fluoride and calcidiol on the rib cortical-endosteal surface remodeling in dogs receiving prednisone.
    Galus K; Talalaj M; Madej K; Wall W; Orlowski T
    Miner Electrolyte Metab; 1992; 18(6):337-42. PubMed ID: 1291853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats.
    Yamamoto M; Markatos A; Seedor JG; Masarachia P; Gentile M; Rodan GA; Balena R
    Calcif Tissue Int; 1993 Oct; 53(4):278-82. PubMed ID: 8275357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.